JPWO2021209564A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021209564A5 JPWO2021209564A5 JP2022562976A JP2022562976A JPWO2021209564A5 JP WO2021209564 A5 JPWO2021209564 A5 JP WO2021209564A5 JP 2022562976 A JP2022562976 A JP 2022562976A JP 2022562976 A JP2022562976 A JP 2022562976A JP WO2021209564 A5 JPWO2021209564 A5 JP WO2021209564A5
- Authority
- JP
- Japan
- Prior art keywords
- biological sample
- nucleic acid
- acetonitrile
- virus
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims description 99
- 239000012472 biological sample Substances 0.000 claims description 98
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 78
- 108020004707 nucleic acids Proteins 0.000 claims description 70
- 102000039446 nucleic acids Human genes 0.000 claims description 70
- 150000007523 nucleic acids Chemical class 0.000 claims description 70
- 239000003960 organic solvent Substances 0.000 claims description 45
- 239000000523 sample Substances 0.000 claims description 31
- 241000700605 Viruses Species 0.000 claims description 30
- 239000002245 particle Substances 0.000 claims description 24
- 230000003321 amplification Effects 0.000 claims description 20
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 20
- 239000003463 adsorbent Substances 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims description 12
- 241001678559 COVID-19 virus Species 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 238000001514 detection method Methods 0.000 claims description 10
- 102000016911 Deoxyribonucleases Human genes 0.000 claims description 8
- 108010053770 Deoxyribonucleases Proteins 0.000 claims description 8
- 230000015556 catabolic process Effects 0.000 claims description 8
- 238000006731 degradation reaction Methods 0.000 claims description 8
- 230000000415 inactivating effect Effects 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 102000006382 Ribonucleases Human genes 0.000 claims description 7
- 108010083644 Ribonucleases Proteins 0.000 claims description 7
- 108020000999 Viral RNA Proteins 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 241000701022 Cytomegalovirus Species 0.000 claims description 6
- 241000701085 Human alphaherpesvirus 3 Species 0.000 claims description 6
- 238000007865 diluting Methods 0.000 claims description 6
- 108020005202 Viral DNA Proteins 0.000 claims description 5
- 238000007664 blowing Methods 0.000 claims description 5
- 230000001681 protective effect Effects 0.000 claims description 5
- 239000002299 complementary DNA Substances 0.000 claims description 4
- 238000009833 condensation Methods 0.000 claims description 4
- 230000005494 condensation Effects 0.000 claims description 4
- 238000003757 reverse transcription PCR Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 241000711573 Coronaviridae Species 0.000 claims description 3
- 108020004414 DNA Proteins 0.000 claims description 3
- 241000701044 Human gammaherpesvirus 4 Species 0.000 claims description 3
- 241000829111 Human polyomavirus 1 Species 0.000 claims description 3
- 102100034343 Integrase Human genes 0.000 claims description 3
- 201000005505 Measles Diseases 0.000 claims description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 3
- 241000702670 Rotavirus Species 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000002594 sorbent Substances 0.000 claims description 3
- 241000712461 unidentified influenza virus Species 0.000 claims description 3
- RLLPVAHGXHCWKJ-IEBWSBKVSA-N (3-phenoxyphenyl)methyl (1s,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-IEBWSBKVSA-N 0.000 claims description 2
- 238000011529 RT qPCR Methods 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims description 2
- 238000004891 communication Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 241000700584 Simplexvirus Species 0.000 claims 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 206010022000 influenza Diseases 0.000 description 6
- 208000030507 AIDS Diseases 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 241000725303 Human immunodeficiency virus Species 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 206010059313 Anogenital warts Diseases 0.000 description 2
- 208000025721 COVID-19 Diseases 0.000 description 2
- 201000006082 Chickenpox Diseases 0.000 description 2
- 208000000907 Condylomata Acuminata Diseases 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 208000004898 Herpes Labialis Diseases 0.000 description 2
- 208000009889 Herpes Simplex Diseases 0.000 description 2
- 241000701806 Human papillomavirus Species 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010067152 Oral herpes Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 241000725643 Respiratory syncytial virus Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 206010046980 Varicella Diseases 0.000 description 2
- 208000025009 anogenital human papillomavirus infection Diseases 0.000 description 2
- 201000004201 anogenital venereal wart Diseases 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 229940096437 Protein S Drugs 0.000 description 1
- 101710198474 Spike protein Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- -1 cell wall Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000779 depleting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000006163 transport media Substances 0.000 description 1
Applications Claiming Priority (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063010455P | 2020-04-15 | 2020-04-15 | |
US63/010,455 | 2020-04-15 | ||
US202063042552P | 2020-06-22 | 2020-06-22 | |
US63/042,552 | 2020-06-22 | ||
US202063049626P | 2020-07-08 | 2020-07-08 | |
US63/049,626 | 2020-07-08 | ||
US202063052269P | 2020-07-15 | 2020-07-15 | |
US63/052,269 | 2020-07-15 | ||
US202063073447P | 2020-09-01 | 2020-09-01 | |
US63/073,447 | 2020-09-01 | ||
US202063124048P | 2020-12-10 | 2020-12-10 | |
US63/124,048 | 2020-12-10 | ||
US202163163032P | 2021-03-18 | 2021-03-18 | |
US63/163,032 | 2021-03-18 | ||
US202163164520P | 2021-03-22 | 2021-03-22 | |
US63/164,520 | 2021-03-22 | ||
PCT/EP2021/059815 WO2021209564A2 (en) | 2020-04-15 | 2021-04-15 | Methods, devices and kits for preparing nucleic acid samples for storage and analysis |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023522054A JP2023522054A (ja) | 2023-05-26 |
JPWO2021209564A5 true JPWO2021209564A5 (de) | 2024-04-01 |
Family
ID=75581514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022562976A Pending JP2023522054A (ja) | 2020-04-15 | 2021-04-15 | 保存および分析のための核酸試料を調製する方法、装置、およびキット |
Country Status (5)
Country | Link |
---|---|
US (1) | US20210355525A1 (de) |
EP (1) | EP4136226A2 (de) |
JP (1) | JP2023522054A (de) |
GB (1) | GB2595572A (de) |
WO (1) | WO2021209564A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2609476A (en) * | 2021-08-04 | 2023-02-08 | Laing Jason | Vapour sample collection device |
US20230091650A1 (en) | 2021-09-20 | 2023-03-23 | Vosbio, Inc. | Devices, Methods and Kits for Biological Sample Capture and Processing |
CN114107571A (zh) * | 2022-01-18 | 2022-03-01 | 复旦大学附属中山医院 | 用于bk病毒lamp检测的试剂盒 |
CN115553286A (zh) * | 2022-09-23 | 2023-01-03 | 深圳微辰生命科技有限公司 | 一种粪便保存液、保存粪便的方法及乙腈在制备粪便保存液中的应用 |
US11805995B1 (en) * | 2022-11-22 | 2023-11-07 | King Faisal University | Saliva collection kit |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7601491B2 (en) * | 2003-02-06 | 2009-10-13 | Becton, Dickinson And Company | Pretreatment method for extraction of nucleic acid from biological samples and kits therefor |
US8080645B2 (en) * | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
US9683256B2 (en) * | 2007-10-01 | 2017-06-20 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system |
US11041216B2 (en) * | 2007-10-01 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples |
GB2522471A (en) * | 2014-01-27 | 2015-07-29 | Uwe Warnken | Compositions for cells lysis and uses thereof |
US9528105B2 (en) * | 2014-09-04 | 2016-12-27 | Techlab, Inc. | Nucleic acid extraction using organic solvents to remove inhibitors |
WO2018126119A1 (en) * | 2016-12-30 | 2018-07-05 | Lee Luke P | Aerosol capture and processing device |
WO2018198682A1 (ja) * | 2017-04-26 | 2018-11-01 | 東洋紡株式会社 | ウイルスの検査方法およびウイルスの検査用キット |
-
2021
- 2021-04-15 US US17/231,234 patent/US20210355525A1/en active Pending
- 2021-04-15 WO PCT/EP2021/059815 patent/WO2021209564A2/en unknown
- 2021-04-15 EP EP21719891.0A patent/EP4136226A2/de active Pending
- 2021-04-15 GB GB2105390.5A patent/GB2595572A/en active Pending
- 2021-04-15 JP JP2022562976A patent/JP2023522054A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111363729B (zh) | 一种rna病毒灭活保存液及其应用 | |
US20210355525A1 (en) | Methods, Devices and Kits for Preparing Nucleic Acid Samples For Storage and Analysis | |
Rahmani et al. | Sampling and detection of corona viruses in air: A mini review | |
CN111088319B (zh) | 一种灭活型病毒样本rna保存液及其制备方法 | |
CN111718908A (zh) | 病毒样本保存液及其制备方法和应用 | |
CN109306350A (zh) | 一种核酸释放剂以及核酸现场释放方法 | |
CN112322697A (zh) | 一种dna样本保存液及其制备方法与应用 | |
US20220061823A1 (en) | Method for obtaining exhaled respiratory specimens | |
Moss et al. | Comparison of the plaque test and reverse transcription nested PCR for the detection of FMDV in nasal swabs and probang samples | |
Sarangi et al. | Evaluation of a specialized filter-paper matrix for transportation of extended bovine semen to screen for bovine herpesvirus-1 by real-time PCR | |
CN114621948A (zh) | 一种高效核酸提取试剂盒及其使用方法 | |
JPWO2021209564A5 (de) | ||
CN101979516A (zh) | 一种病毒采样液组合物 | |
CN113736748A (zh) | 一种样本保存液及其应用 | |
JP2015525890A (ja) | 定性および定量分析のための生体標本を保存するためのマトリックスおよびシステム | |
CN111621481B (zh) | 呼吸道病毒处理试剂及其应用 | |
CN111850090A (zh) | 一种有效保存病毒样品的病毒保存液 | |
US20230366043A1 (en) | Method for detection of rna or dna from bological samples | |
CN111411169A (zh) | 用于恒温扩增检测麻疹病毒的核酸序列、试剂盒及方法和应用 | |
Singh et al. | An alkaline solution simplifies nucleic acid preparation for RT-PCR and infectivity assays of viroids from crude sap and spotted membrane | |
Evers et al. | Effect of preservative on recoverable RT-PCR amplicon length from influenza A virus in bird feces | |
van Vuren et al. | Chemical inactivation of foot-and-mouth disease virus in bovine tongue epithelium for safe transport and downstream processing | |
Hemida et al. | The Middle East respiratory syndrome coronavirus in the breath of some infected dromedary camels (Camelus dromedarius) | |
CN112266910A (zh) | 一种核酸释放剂及其核酸释放方法 | |
RU2610434C1 (ru) | Набор олигодезоксирибонуклеотидных праймеров и флуоресцентно-меченых ДНК-зондов для идентификации РНК энтеровирусов, ротовирусов, вирусов гепатита А и Е, аденовирусов, норовирусов и астровирусов из водной среды методом мультиплексной ПЦР |